Such mutations, which result in ~ 50% reductions of progranulin protein (PGRN) levels [11–13], also rarely cause FTD-ALS [14] and genetic variations in GRN have been associated with the age of onset, disease duration and risk of disease in ALS [15]. This evidence concerns the gene GRN and frontotemporal dementia.